Drug interactions
Empagliflozin-linagliptin + Pioglitazone
Severity: Minor
Empagliflozin-linagliptin and Pioglitazone: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
No meaningful pharmacokinetic interaction is expected between linagliptin and pioglitazone, and they are often combined. The combination adds glucose-lowering effect, with fluid retention from pioglitazone being a separate consideration.
What this interaction means in plain words
Empagliflozin-linagliptin and Pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Empagliflozin-linagliptin belongs to Endocrine; Pioglitazone belongs to Endocrine.
Why it happens
Complementary pharmacodynamic glucose-lowering; pioglitazone is not a clinically relevant CYP3A4 inducer.
What to do
No dose adjustment is required. Monitor glycemic control and signs of fluid retention.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Empagliflozin-linagliptin and Pioglitazone, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Empagliflozin-linagliptin
Other interactions of Pioglitazone
Frequently asked questions
Can I take Empagliflozin-linagliptin with Pioglitazone?
MediHelp rates the interaction as minor. Empagliflozin-linagliptin and Pioglitazone have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. No meaningful pharmacokinetic interaction is expected between linagliptin and pioglitazone, and they are often combined. The combination adds glucose-lowering effect, with fluid retention from pioglitazone being a separate consideration.
How serious is the interaction between Empagliflozin-linagliptin and Pioglitazone?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is required. Monitor glycemic control and signs of fluid retention.
What other medicines interact with Empagliflozin-linagliptin?
MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Fosphenytoin, Rifampin, Rifapentine. The full list is on the Empagliflozin-linagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
